lunes, 14 de marzo de 2022

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

No hay comentarios:

Publicar un comentario